MedPath
NMPA Approval

Mosunetuzumab Injection

国药准字SJ20240049

December 17, 2024

Drug Information

莫妥珠单抗注射液

皓罗华

注射剂

30mg(30ml)/瓶

生物制品

December 17, 2024

December 16, 2028

Company Information

Applicant Company

Grenzacherstrasse 124, 4058 Basel, Switzerland

Manufacturing Company

GENENTECH, INC.

1 DNA Way, South San Francisco, CA 94080, USA

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

莫妥珠单抗注射液 - NMPA 批准文号 | MedPath